Latest Profitability News

Bubs Australia reported a 30% increase in net revenue to $25.6 million for Q1 FY26, driven by robust US sales and a return to profitability with positive EBITDA. Despite inventory challenges in other regions, the company maintains a solid cash position and anticipates FDA approval by year-end.

Mach7 Technologies reports a modest rise in recurring revenue alongside a comprehensive commercial transformation, positioning itself for growth in AI-driven medical imaging.

Mach7 Technologies reports a pivotal first quarter for FY26, marked by the initial go-live of a major U.S. Veterans Health Administration contract, leadership changes, and a strategic business reset.

Jupiter Mines reported a 5% increase in manganese production for Q1 FY2026, yet sales volumes and EBITDA declined, reflecting a complex market environment. Despite these shifts, the company maintains a strong cash position and steady manganese prices.

Aspermont Limited reports a milestone $11.2 million annual recurring revenue with its new Mining-IQ platform gaining traction through a landmark Rio Tinto contract. The company also strengthens its balance sheet with a $2.8 million capital raise, setting the stage for accelerated growth.

CAR Group Limited has reported robust FY25 financial results with strong revenue and profit growth, underpinned by strategic investments in AI and digital marketplaces. The company projects continued momentum into FY26, aiming to deepen market leadership across global regions.

Farm Pride Foods reported a solid $3.58 million net operating cash inflow for the September quarter, despite ongoing pricing pressures. The company is investing in operational upgrades and has commenced construction of a large new hen rearing farm in Victoria.

IMEXHS Limited reported a 9% rise in Q3 FY25 revenue and a positive swing to $0.6m underlying EBITDA, reaffirming full-year guidance. Key contract wins and AI-driven efficiencies underpin margin gains despite political uncertainties in Colombia.

AVADA Group Limited reported a revenue increase in Q1 FY26 despite ending a major contract, alongside a significant reduction in operating cash outflows and ongoing debt repayments.

Nova Eye Medical reported a robust 32% increase in global sales excluding China for Q1 FY26 and secured regulatory approval for its iTrack™ Advance device in China, setting the stage for expanded market penetration.

Capstone Copper delivered a landmark Q3 2025 with record revenue, lowest-ever cash costs, and a strategic joint venture that derisks its Santo Domingo project. The company’s growth trajectory is bolstered by robust production gains and promising exploration results.

Cluey Ltd has reported its strongest-ever underlying EBITDA alongside improved cash flow, while ramping up investments in AI-powered product development set to launch in 2026.